CN1488331A - A superporous hydrogel composite, its preparation method and its application in pharmacy - Google Patents
A superporous hydrogel composite, its preparation method and its application in pharmacy Download PDFInfo
- Publication number
- CN1488331A CN1488331A CNA031422314A CN03142231A CN1488331A CN 1488331 A CN1488331 A CN 1488331A CN A031422314 A CNA031422314 A CN A031422314A CN 03142231 A CN03142231 A CN 03142231A CN 1488331 A CN1488331 A CN 1488331A
- Authority
- CN
- China
- Prior art keywords
- acrylic acid
- superporous hydrogels
- methyl
- cross
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
技术领域technical field
本发明属高分子材料技术领域,具体涉及一种超多孔水凝胶复合物,其制备方法及其在药剂学中的应用。The invention belongs to the technical field of polymer materials, and in particular relates to a superporous hydrogel compound, its preparation method and its application in pharmacy.
背景技术Background technique
水凝胶是含有网络结构的交联的亲水性高分子聚合物。它在水中不溶,但能吸收大量的水分。水凝胶的研究始于二十世纪六十年代,由于其具有生物相容性及生物可降解性等性质,可广泛用于医学、生物学以及药学领域,到目前为止已发明了多种水凝胶。Hydrogels are cross-linked hydrophilic polymers containing a network structure. It is insoluble in water but absorbs large amounts of water. The study of hydrogel began in the 1960s. Due to its biocompatibility and biodegradability, it can be widely used in the fields of medicine, biology and pharmacy. So far, a variety of hydrogels have been invented. gel.
就水凝胶的膨胀性能而言,可将其分为如下两种:即传统的水凝胶和新型的水凝胶。二者最重要的差异是它们的膨胀性质。水凝胶的膨胀性质主要与网络结构的弹性、高分子聚合物链段中的亲水性官能团的有无、交联的程度以及高分子聚合物的孔隙率有关。除此以外,离子间的相互作用和溶剂介导效应也对其有影响。传统水凝胶由于其刚性的晶状结构及聚合物链段的较低的弹性,使得其膨胀非常慢。普通药片大小(直径1厘米,厚0.5厘米)的水凝胶达溶胀平衡的时间通常为几小时,甚至几天。在应用时需预先溶胀水凝胶。而新型的超多孔水凝胶(superporous gydrogels)由于含有大量的相互交联的孔道,大大增加了水凝胶内部的表面积,使得其吸水很快,通常为几秒至几小时。但是,其机械强度较差。As far as the swelling properties of hydrogels are concerned, they can be divided into the following two types: traditional hydrogels and new hydrogels. The most important difference between the two is their expansive nature. The swelling properties of hydrogel are mainly related to the elasticity of the network structure, the presence or absence of hydrophilic functional groups in the polymer chain segment, the degree of crosslinking and the porosity of the polymer. In addition, the interaction between ions and solvent-mediated effects also affect it. Conventional hydrogels swell very slowly due to their rigid crystalline structure and low elasticity of polymer chain segments. The time for a hydrogel of the size of an ordinary tablet (diameter 1 cm, thickness 0.5 cm) to reach swelling equilibrium is usually several hours or even several days. The hydrogel needs to be pre-swelled for application. The new superporous hydrogels (superporous gydrogels) greatly increase the internal surface area of the hydrogel due to the large number of cross-linked pores, which makes them absorb water very quickly, usually for a few seconds to several hours. However, its mechanical strength is poor.
美国专利6271278公开了一种超多孔水凝胶复合物,在一种崩解剂和一种起泡剂的存在下,通过把一种或多种不饱和烯单体和一种多烯交联剂聚合而形成。该发明所公开的超多孔水凝胶由于含有大量的羧酸基团,其具有一定的生物粘附性和抑制蛋白酶的作用。但超多孔水凝胶复合物,由于崩解剂的加入使得其生物粘附性及抑制蛋白酶的作用下降。U.S. Patent 6271278 discloses a superporous hydrogel composite, in the presence of a disintegrant and a foaming agent, by crosslinking one or more ethylenically unsaturated monomers and a polyene Formed by polymerization. The superporous hydrogel disclosed in the invention has a certain bioadhesion and protease inhibitory effect due to containing a large number of carboxylic acid groups. However, due to the addition of disintegrants, the superporous hydrogel composites have decreased bioadhesion and protease inhibition.
发明内容Contents of the invention
本发明的目的在于提供一种膨胀速度快、机械强度高、且对生物粘附性和抑制蛋白酶作用好的超多孔水凝胶复合物及其制备方法,以及它在药剂学中应用,以克服现有技术的不足和缺陷。The object of the present invention is to provide a superporous hydrogel composite with fast expansion speed, high mechanical strength, good bioadhesion and protease inhibition and its preparation method, and its application in pharmacy to overcome Deficiencies and defects of the prior art.
卡波沫(Carbomer)是聚烷基蔗糖和聚烷基季戊四醇与丙烯酸交联聚合物的共聚物。由于分子中存在大量的羧酸基团,其与聚丙烯酸有非常相似的物理性质和化学性质,同时,在结构中微弱的交联键又使之与交联聚丙烯酸钠具有相似的吸水现象。卡波沫可以在水中迅速溶胀,但不溶解。并且卡波沫所形成的凝胶具有一定的强度和弹性。卡波沫分子中的羧酸基团可形成大量的氢键,一方面使其极易在水中膨胀,可以产生很大的粘附面积,最大限度地与粘膜蛋白接触;另一方面,丙烯酸类聚合物通过氢键与粘蛋白的相互作用,可使聚合物与粘蛋白之间产生粘性作用。并且聚合物膨胀的越快,它与粘蛋白发生作用就越快,从而保证了强的粘性。Carbomer is a copolymer of polyalkyl sucrose and polyalkyl pentaerythritol with acrylic acid crosslinked polymer. Due to the presence of a large number of carboxylic acid groups in the molecule, it has very similar physical and chemical properties to polyacrylic acid, and at the same time, the weak cross-linking bonds in the structure make it have a similar water absorption phenomenon to cross-linked sodium polyacrylate. Carbomer swells rapidly in water but does not dissolve. And the gel formed by carbomer has certain strength and elasticity. The carboxylic acid groups in the carbomer molecule can form a large number of hydrogen bonds. On the one hand, it is easy to swell in water, which can produce a large adhesion area and maximize contact with mucous membrane proteins; on the other hand, acrylic acid The interaction between the polymer and the mucin through hydrogen bonds can cause a viscous interaction between the polymer and the mucin. And the faster the polymer swells, the faster it interacts with mucin, thus ensuring a strong stickiness.
本发明提出的超多孔水凝胶复合物,是在超多孔水凝胶中加入卡波林而制备获得,它既具有超多孔水凝胶的快速膨胀的性质,又因卡波沫的加入,机械强度增加,并且具有良好的生物粘附性能和对蛋白酶的抑制作用,从而使该水凝胶复合物有利于蛋白质多肽类药物的口服给药及用于胃漂浮制剂。The superporous hydrogel composite proposed by the present invention is prepared by adding carbolin into the superporous hydrogel. It not only has the property of rapid expansion of the superporous hydrogel, but also because of the addition of carbomer, The mechanical strength is increased, and it has good bioadhesive properties and inhibitory effect on protease, so that the hydrogel complex is beneficial for oral administration of protein polypeptide drugs and for gastric floating preparations.
本发明的超多孔水凝胶复合物,含有交联聚合物和卡波沫,并具有超多孔结构,该聚合物由至少一种不饱和烯单体和多烯交联剂聚合形成;其中卡波沫与聚合物的重量比为0.05∶100到15∶100,交联剂与单体的重量比为0.01∶100到10∶100。The superporous hydrogel composite of the present invention contains a crosslinked polymer and carbomer, and has a superporous structure, and the polymer is formed by polymerization of at least one unsaturated ethylenic monomer and a polyene crosslinking agent; wherein the carbomer The weight ratio of foam to polymer is 0.05:100 to 15:100, and the weight ratio of crosslinking agent to monomer is 0.01:100 to 10:100.
所说的不饱和烯单体可以为(甲基)丙烯酸、(甲基)丙烯酸盐类、(甲基)丙烯酸酯类、(甲基)丙烯酸酯的盐类或酸类、(甲基)丙烯酸的酰胺类、(甲基)丙烯酸的N-烷基酰胺类、(甲基)丙烯酸的N-烷基酰胺类的盐类和酸类、N-乙烯基吡咯烷酮、丙烯酰胺、丙烯酰胺衍生物、甲基丙烯酰胺、甲基丙烯酰胺衍生物中一种或几种。Said unsaturated ethylenic monomers can be (meth)acrylic acid, (meth)acrylic acid salts, (meth)acrylic acid esters, (meth)acrylic acid ester salts or acids, (meth)acrylic acid N-alkylamides of (meth)acrylic acid, salts and acids of N-alkylamides of (meth)acrylic acid, N-vinylpyrrolidone, acrylamide, acrylamide derivatives, One or more of methacrylamide and methacrylamide derivatives.
通常所用的不饱和烯单体为丙烯酰胺、N-异丙基丙烯酰胺、2-羟乙基甲基丙烯酸酯、2-羟丙基甲基丙烯酸酯、N-乙烯基吡咯烷酮、丙烯酸、2-丙烯酰胺-2-甲基-1-丙磺酸、3-磺丙基-丙烯酸钾盐中的一种或几种。Commonly used ethylenically unsaturated monomers are acrylamide, N-isopropylacrylamide, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, N-vinylpyrrolidone, acrylic acid, 2- One or more of acrylamide-2-methyl-1-propanesulfonic acid, 3-sulfopropyl-acrylic acid potassium salt.
所说的交联剂为N,N-亚甲基-双丙烯酰胺(Bis)、二(甲基)丙烯酸乙二醇酯、哌嗪二丙烯酰胺、戊二醛、表氯醇、含1,2二醇结构的交联剂、含功能肽的交联剂和含蛋白质的交联剂。Said cross-linking agent is N, N-methylene-bisacrylamide (Bis), ethylene glycol di(meth)acrylate, piperazine diacrylamide, glutaraldehyde, epichlorohydrin, containing 1, 2 Diol structure cross-linking agent, functional peptide-containing cross-linking agent and protein-containing cross-linking agent.
本发明的超多孔水凝胶复合物,其平均孔径为50μm至4000μm。优选的平均孔径为100μm至800μm。由于大量孔隙的存在并且它们彼此相互连接,所以该水凝胶复合物膨胀很快并且其达到溶胀平衡的时间也很短。本发明的超多孔水凝胶复合物的溶胀比为5至2000,较好的溶胀比为5-800。达到溶胀平衡的时间为1秒至2小时,较好的溶胀平衡时间为1秒至30分钟。The superporous hydrogel composite of the present invention has an average pore diameter of 50 μm to 4000 μm. A preferred average pore size is 100 μm to 800 μm. Due to the existence of a large number of pores and their interconnection with each other, the hydrogel composite swells very quickly and its time to reach swelling equilibrium is also very short. The swelling ratio of the superporous hydrogel composite of the present invention is 5 to 2000, and the preferred swelling ratio is 5-800. The time to reach swelling equilibrium is 1 second to 2 hours, and the better swelling equilibrium time is 1 second to 30 minutes.
本发明提出的上述超多孔水凝胶复合物,其制备方法如下:The above-mentioned superporous hydrogel composite that the present invention proposes, its preparation method is as follows:
(1)将至少一种不饱和烯单体、一种多烯交联剂、卡波沫和一种起泡剂按重量配比混合;(1) at least one unsaturated ethylenic monomer, a polyene crosslinking agent, carbomer and a foaming agent are mixed by weight;
(2)上述混合物在聚合和起泡的条件下形成超多孔水凝胶复合物。(2) The above mixture forms a superporous hydrogel composite under the conditions of polymerization and foaming.
其中卡波沫与聚合物(由至少一种不饱和烯单体和多烯交联剂聚合形成)的比率在0.05∶100到15∶100的范围内。卡波沫的用量太大,在聚合过程中不能将其全部包含到聚合物中,有部分卡波沫不发生胶凝。所说的不饱和烯单体为(甲基)丙烯酸、(甲基)丙烯酸盐类、(甲基)丙烯酸酯类、(甲基)丙烯酸酯的盐类或酸类、(甲基)丙烯酸的酰胺类、(甲基)丙烯酸的N-烷基酰胺类、(甲基)丙烯酸的N-烷基酰胺类的盐类和酸类、N-乙烯基吡咯烷酮、丙烯酰胺、丙烯酰胺衍生物、甲基丙烯酰胺、甲基丙烯酰胺衍生物中一种或一种以上。Wherein the ratio of carbomer to polymer (formed by polymerization of at least one ethylenically unsaturated monomer and polyene crosslinking agent) is in the range of 0.05:100 to 15:100. The amount of carbomer used is too large, and it cannot be completely included in the polymer during the polymerization process, and some carbomer does not gel. Said unsaturated ethylenic monomers are (meth)acrylic acid, (meth)acrylic acid salts, (meth)acrylic acid esters, (meth)acrylic acid ester salts or acids, (meth)acrylic acid Amides, N-alkylamides of (meth)acrylic acid, salts and acids of N-alkylamides of (meth)acrylic acid, N-vinylpyrrolidone, acrylamide, acrylamide derivatives, formaldehyde One or more of methacrylamide and methacrylamide derivatives.
通常所用的不饱和烯单体为丙烯酰胺、N-异丙基丙烯酰胺、2-羟乙基甲基丙烯酸酯、2-羟丙基甲基丙烯酸酯、N-乙烯基吡咯烷酮、丙烯酸、2-丙烯酰胺-2-甲基-1-丙磺酸、3-磺丙基-丙烯酸钾盐中的一种或一种以上。Commonly used ethylenically unsaturated monomers are acrylamide, N-isopropylacrylamide, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, N-vinylpyrrolidone, acrylic acid, 2- One or more of acrylamide-2-methyl-1-propanesulfonic acid, 3-sulfopropyl-acrylic acid potassium salt.
所说的交联剂为N,N-亚甲基-双丙烯酰胺、二(甲基)丙烯酸乙二醇酯、哌嗪二丙烯酰胺、戊二醛、表氯醇、含1,2二醇结构的交联剂、含功能肽的交联剂和含蛋白质的交联剂。其用量为交联剂与单体的比率在0.01∶100到10∶100的范围内。优选的交联剂与单体的比率在1∶100。交联剂浓度太高,引起溶胀的超多孔水凝胶复合物变得易碎,导致溶胀比的降低。反之,交联剂的浓度太低,造成超多孔水凝胶复合物变得更软和易碎。Said cross-linking agent is N, N-methylene-bisacrylamide, ethylene glycol di(meth)acrylate, piperazine diacrylamide, glutaraldehyde, epichlorohydrin, containing 1,2 glycol Structural cross-linking agents, functional peptide-containing cross-linking agents and protein-containing cross-linking agents. The amount used is such that the ratio of crosslinker to monomer is in the range of 0.01:100 to 10:100. A preferred ratio of crosslinker to monomer is 1:100. Too high concentration of cross-linking agent caused the swollen superporous hydrogel composite to become brittle, resulting in a decrease in the swelling ratio. On the contrary, the concentration of cross-linking agent is too low, resulting in softer and brittle superporous hydrogel composites.
所说的起泡剂为碳酸氢盐、碳酸盐的一种或一种以上或从外导入气泡。其中常用的为碳酸氢钠、碳酸钠和碳酸钙的一种或一种以上。优选的为碳酸氢钠。其加入量为给出质子单体的0.5-1.5重量比。Said foaming agent is one or more of bicarbonate and carbonate or introduces bubbles from the outside. One or more of sodium bicarbonate, sodium carbonate and calcium carbonate are commonly used. Preferred is sodium bicarbonate. Its addition amount is 0.5-1.5 weight ratio of proton-giving monomer.
形成超多孔水凝胶复合物的两个必备的条件为聚合和起泡。在聚合和起泡之前,应先加入所需要的水。为了制备均相超多孔水凝胶复合物,聚合和起泡应当同时发生。因为起泡过程较短并很难稳定气泡长于几分钟,为捕获聚合物网络中的气泡,在气泡稳定时必须发生胶凝。The two necessary conditions for the formation of superporous hydrogel composites are aggregation and foaming. The required water should be added prior to polymerization and foaming. In order to prepare homogeneous superporous hydrogel composites, polymerization and foaming should occur simultaneously. Because the foaming process is short and it is difficult to stabilize the bubbles for longer than a few minutes, in order to trap the bubbles in the polymer network, gelation must occur while the bubbles are stabilizing.
起泡的方法多种多样,包括化学试剂的热分解、机械抖动、低沸点液体的挥发、化学反应、释压时溶解气体的膨胀等化学或机械方法。起泡剂的用量决定气泡孔径的大小和超多孔水凝胶复合物的孔隙率。气泡产生后,为使其在胶凝过程中稳定,需使用泡沫稳定剂,其通过降低膜-气界面张力和增加膜粘度来稳定泡沫。。理想的泡沫稳定剂应当把泡沫稳定到胶凝过程的开始。Pluronic F127(泊洛沙姆)是一种较好的泡沫稳定剂,其稳定泡沫的时间较长。但其用量有一定的要求,太少不能提供较好的泡沫稳定效果,而超过一定量同样达不到稳定泡沫的效果。一般来讲,其用量为0.4-0.7%(W/W)。本发明中使用了卡波洙,随着卡波洙的用量的增加,可以观察到气泡的产生高度增加。并且如果卡波沫的加入量合适,气泡的稳定性增加。卡波沫对气泡的稳定有辅助作用。There are various methods of foaming, including chemical or mechanical methods such as thermal decomposition of chemical reagents, mechanical shaking, volatilization of low-boiling liquids, chemical reactions, and expansion of dissolved gases when pressure is released. The amount of foaming agent determines the pore size of the bubbles and the porosity of the superporous hydrogel composite. After the bubbles are generated, to stabilize them during the gelation process, foam stabilizers are used, which stabilize the foam by reducing the film-air interfacial tension and increasing the film viscosity. . An ideal foam stabilizer should stabilize the foam until the onset of the gelling process. Pluronic F127 (poloxamer) is a better foam stabilizer, which stabilizes the foam for a longer time. However, there are certain requirements for its dosage, too little can not provide a good foam stabilization effect, and more than a certain amount can not achieve the same foam stabilization effect. Generally speaking, its dosage is 0.4-0.7% (W/W). Carbosol is used in the present invention, and with the increase of the amount of carbose, it can be observed that the generation height of the bubbles increases. And if the amount of carbomer added is appropriate, the stability of the bubbles increases. Carbomer plays an auxiliary role in stabilizing the bubbles.
上述方法中,在聚合和起泡之前,在混合物中还可加入引发剂和催化剂,以改善聚合速度。In the above method, before the polymerization and foaming, an initiator and a catalyst can also be added to the mixture to improve the polymerization speed.
本发明中,在有酸存在时选用碳酸氢钠作为起泡剂来制备超多孔水凝胶复合物,因为碳酸氢钠-酸体系具有其它气体喷吹技术没有的优点。它安全、低廉、容易使用,且允许人为控制形成泡沫的时间和在聚合过程中导入的气体的量。In the present invention, sodium bicarbonate is selected as the foaming agent to prepare superporous hydrogel composites in the presence of acid, because the sodium bicarbonate-acid system has advantages that other gas injection techniques do not have. It is safe, inexpensive, easy to use, and allows artificial control of the time of foam formation and the amount of gas introduced during polymerization.
通过控制单体(种类和浓度)、引发剂(种类和浓度)、温度和溶剂可达到快速胶凝。通常水溶性的丙烯酸盐、甲基丙烯酸盐和丙烯酰胺胶凝非常快,因此,优选上述单体制备超多孔水凝胶复合物。Rapid gelation can be achieved by controlling monomer (type and concentration), initiator (type and concentration), temperature and solvent. Generally, water-soluble acrylates, methacrylates, and acrylamides gel very quickly, so the above-mentioned monomers are preferred to prepare superporous hydrogel composites.
优选使用过硫酸铵作为引发剂,N,N,N′,N′-四甲基乙二胺(TMEDA)作为催化剂,引发剂和催化剂的用量可影响聚合的速度。通常,过硫酸铵的浓度和N,N,N′,N′-四甲基乙二胺的浓度约为单体的1.5-2.5%(W/W)。Ammonium persulfate is preferably used as the initiator, and N,N,N',N'-tetramethylethylenediamine (TMEDA) is used as the catalyst, and the amount of the initiator and the catalyst can affect the polymerization rate. Typically, the concentration of ammonium persulfate and N,N,N',N'-tetramethylethylenediamine is about 1.5-2.5% (W/W) of the monomer.
本发明的超多孔水凝胶复合物的溶胀比、密度和生物粘附力的测定方法如下:The measuring method of the swelling ratio, density and bioadhesion of superporous hydrogel composite of the present invention is as follows:
溶胀比的测定:溶胀比的定义为Q=(Ws-Wd)/Wd,其中Ws是溶胀后的超多孔水凝胶复合物的重量,Wd是干超多孔水凝胶复合物的重量。首先称重干超多孔水凝胶复合物,得到Wd,把样品置于过量的双蒸水中,用带筛网的容器定时取出,去掉筛网中剩余的水,然后称重,得到Ws,即可求得溶胀比Q。Determination of swelling ratio: The swelling ratio is defined as Q=(Ws-Wd)/Wd, wherein Ws is the weight of the swollen superporous hydrogel composite, and Wd is the weight of the dry superporous hydrogel composite. First weigh the dry superporous hydrogel composite to obtain Wd, place the sample in excess double-distilled water, take it out regularly with a container with a screen, remove the remaining water in the screen, and then weigh it to obtain Ws, namely The swelling ratio Q can be obtained.
密度的测定:密度为d=Wd/Vd,其中Wd是干超多孔水凝胶复合物的重量,Vd是超多孔水凝胶复合物的体积。其中Vd是利用溶剂替换法测得,即将超多孔水凝胶复合物置于已测得直径和高度的、装有正己烷的圆柱形试管中,通过高度的变化得知Vd,从而求得密度。Determination of density: the density is d=Wd/Vd, wherein Wd is the weight of the dry superporous hydrogel composite, and Vd is the volume of the superporous hydrogel composite. Among them, Vd is measured by solvent replacement method, that is, the superporous hydrogel composite is placed in a cylindrical test tube filled with n-hexane whose diameter and height have been measured, and the Vd is obtained through the change of height, thereby obtaining the density.
生物粘附力的测定:取大鼠的新鲜的胃粘膜和小肠粘膜(不要损伤粘膜层),将超多孔水凝胶以固定体积与粘膜接触,放置10分钟,用改进的精密扭力天平测定。水凝胶和粘膜分离时所需的力即为生物粘附力。Determination of bioadhesive force: take fresh gastric mucosa and small intestinal mucosa of rats (do not damage the mucosal layer), put the superporous hydrogel in contact with the mucosa in a fixed volume, place it for 10 minutes, and measure it with an improved precision torque balance. The force required to separate the hydrogel from the mucosa is known as bioadhesion.
表1 超多孔水凝胶的密度、溶胀比、溶胀时间和生物粘附力(n=3)Table 1 Density, swelling ratio, swelling time and bioadhesion of superporous hydrogels (n=3)
干超多孔水凝胶Dried ultraporous hydrogel
溶胀时间 生物粘附力样品Swrite time Biological adhesion sample
溶胀比
复合物的密度(g/cm3)Density of composite (g/cm 3 )
(min) (mg/mm2)(min) (mg/mm 2 )
1 0.84±0.05 138±16 10±3 23.6±10.21 0.84±0.05 138±16 10±3 23.6±10.2
2 0.68±0.02 146±11 8±4 25.3±12.52 0.68±0.02 146±11 8±4 25.3±12.5
3 0.98±0.02 75±8 90±14 32.6±13.13 0.98±0.02 75±8 90±14 32.6±13.1
4 0.80±0.06 149±21 12±5 24.5±11.34 0.80±0.06 149±21 12±5 24.5±11.3
5 0.73±0.09 131±9 9±3 28.3±12.95 0.73±0.09 131±9 9±3 28.3±12.9
6 0.96±0.01 83±11 86±18 35.4±15.66 0.96±0.01 83±11 86±18 35.4±15.6
*:样品1-6由实施例1-6制得。 * : Samples 1-6 were prepared from Examples 1-6.
本发明提供的超多孔水凝胶复合物,其内部是多孔结构,外部的孔隙较少,类似传统的水凝胶,因而其机械强度较好。The superporous hydrogel composite provided by the invention has a porous structure inside and fewer pores outside, similar to traditional hydrogels, and thus has better mechanical strength.
本发明的超多孔水凝胶复合物对胰蛋白酶有较好的抑制作用。The superporous hydrogel composite of the invention has better inhibitory effect on trypsin.
本发明的超多孔水凝胶复合物,因其密度较小,膨胀很快,机械强度较好且对胃粘膜有粘附能力,可用于胃漂浮制剂的制备。The superporous hydrogel composite of the present invention can be used in the preparation of gastric floating preparations because of its low density, rapid expansion, good mechanical strength and adhesion to gastric mucosa.
本发明的超多孔水凝胶复合物,因其溶胀快,对小肠粘膜的粘附作用以及对蛋白酶的抑制作用,其可用于蛋白质多肽药物的口服给药。The superporous hydrogel complex of the present invention can be used for oral administration of protein polypeptide drugs because of its fast swelling, adhesion to small intestine mucosa and inhibition of protease.
本发明的优点在于:The advantages of the present invention are:
(1)卡波沫有辅助气泡稳定的效果,使得超多孔水凝胶复合物的制备更易行。(1) Carbopol has the effect of assisting the stabilization of bubbles, making the preparation of superporous hydrogel composites easier.
(2)所加入的卡波沫具有快速溶胀的特点,其与超多孔水凝胶形成的复合物仍具有快速溶胀的特性;(2) The added carbomer has the characteristics of rapid swelling, and the composite formed with the superporous hydrogel still has the characteristics of rapid swelling;
(3)由于外部类似传统水凝胶的出现,使得该超多孔水凝胶复合物的机械强度较好;(3) Due to the appearance of the exterior similar to traditional hydrogels, the mechanical strength of the superporous hydrogel composite is better;
(4)卡波沫的加入合适量后,该超多孔水凝胶复合物的密度较小,有利于胃漂浮制剂;(4) After adding an appropriate amount of carbomer, the density of the superporous hydrogel composite is small, which is beneficial to the gastric floating preparation;
(5)卡波沫的加入,使得该超多孔水凝胶复合物具有生物粘附作用和蛋白酶抑制作用,有利于蛋白质多肽药物的口服给药。(5) The addition of carbomer enables the superporous hydrogel complex to have bioadhesion and protease inhibition, which is beneficial to the oral administration of protein and polypeptide drugs.
具体实施方式Detailed ways
实施例1、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 1, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;300μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;100μl 0.4%Carbopol934P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients in turn to a tall weighing bottle: 300 μl 50% acrylamide; 200 μl 50% acrylic acid; 70 μl 2.5% Bis; 300 μl double distilled water; 30 μl 10% Pluronic F127; 25 μl 20% ammonium persulfate; 0.4% Carbopol 934P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例2、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 2, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;300μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;12mg Carbopol934P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients to a tall weighing bottle in turn: 300 μl 50% acrylamide; 200 μl 50% acrylic acid; 70 μl 2.5% Bis; 300 μl double distilled water; 30 μl 10% Pluronic F127; 25 μl 20% ammonium persulfate; 12 mg Carbopol 934P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例3、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 3, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;700μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;50mg Carbopol934P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients to a tall weighing bottle in turn: 300μl 50% acrylamide; 200μl 50% acrylic acid; 70μl 2.5% Bis; 700μl double distilled water; 30μl 10% Pluronic F127; 25μl 20% ammonium persulfate; 50mg Carbopol 934P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例4、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 4, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;300μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;100μl 0.4%Carbopol974P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients in turn to a tall weighing bottle: 300 μl 50% acrylamide; 200 μl 50% acrylic acid; 70 μl 2.5% Bis; 300 μl double distilled water; 30 μl 10% Pluronic F127; 25 μl 20% ammonium persulfate; 0.4% Carbopol 974P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例5、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 5, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;300μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;12mg Carbopol974P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients to a tall weighing bottle in turn: 300 μl 50% acrylamide; 200 μl 50% acrylic acid; 70 μl 2.5% Bis; 300 μl double distilled water; 30 μl 10% Pluronic F127; 25 μl 20% ammonium persulfate; 12 mg Carbopol 974P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例6、聚(丙烯酸和丙烯酰胺)-卡波沫超多孔水凝胶复合物Embodiment 6, poly(acrylic acid and acrylamide)-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酰胺;200μl 50%的丙烯酸;70μl 2.5%Bis;700μl双蒸水;30μl 10%Pluronic F127;25μl 20%的过硫酸铵;50mg Carbopol974P;25μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients to a tall weighing bottle in turn: 300μl 50% acrylamide; 200μl 50% acrylic acid; 70μl 2.5% Bis; 700μl double distilled water; 30μl 10% Pluronic F127; 25μl 20% ammonium persulfate; 50mg Carbopol 974P; 25 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例7、聚丙烯酰胺-卡波沫超多孔水凝胶复合物Embodiment 7, polyacrylamide-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:500μl 50%的丙烯酰胺;100μl 2.5%Bis;300μl双蒸水;40μl 10%Pluronic F127;10μl丙烯酸;20μl 20%的过硫酸铵;12mgCarbopol934P;20μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入50mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following components to a tall weighing bottle in turn: 500 μl 50% acrylamide; 100 μl 2.5% Bis; 300 μl double distilled water; 40 μl 10% Pluronic F127; 10 μl acrylic acid; 20 μl 20% ammonium persulfate; %TEMED. After the addition of each component, the solution was vortex mixed, 50 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例8、聚丙烯酸-卡波沫超多孔水凝胶复合物Embodiment 8, polyacrylic acid-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 50%的丙烯酸(已中和);100μl 2.5%Bis;300μl双蒸水;40μl 10%Pluronic F127;20μl 20%的过硫酸铵;12mgCarbopol934P;20μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入100mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following ingredients to a tall weighing bottle in turn: 300μl 50% acrylic acid (neutralized); 100μl 2.5% Bis; 300μl double distilled water; 40μl 10% Pluronic F127; 20μl 20% ammonium persulfate; 12mgCarbopol934P; 15% TEMED. After the addition of each component, the solution was vortex mixed, 100 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
实施例9、2-羟乙基甲基丙烯酸酯-卡波沫超多孔水凝胶复合物Example 9, 2-hydroxyethyl methacrylate-carbomer superporous hydrogel composite
依次向高型称量瓶中加入下列成分:300μl 2-羟乙基甲基丙烯酸酯;60μl 2.5%Bis;60μl 10%Pluronic F127;涡旋混合;60℃保温,加入20μl 20%的过硫酸铵;12mgCarbopol934P;20μl 15%TEMED。在加入每种成分之后,涡旋混合溶液,在发生胶凝前2分钟加入50mg碳酸氢钠,涡旋振荡20秒。将超多孔水凝胶复合物室温下固化10分钟,55℃干燥20小时。Add the following components to a tall weighing bottle in turn: 300μl 2-hydroxyethyl methacrylate; 60μl 2.5% Bis; 60μl 10% Pluronic F127; vortex mixing; keep warm at 60°C, add 20μl 20% ammonium persulfate ; 12 mg Carbopol 934P; 20 μl 15% TEMED. After the addition of each component, the solution was vortex mixed, 50 mg of sodium bicarbonate was added 2 minutes before gelling, and vortexed for 20 seconds. The superporous hydrogel composite was cured at room temperature for 10 minutes and dried at 55°C for 20 hours.
上述实施例制得的超多孔水凝胶复合物都具有良好的物理和生物性能,具体见表1所示。The superporous hydrogel composites prepared in the above examples all have good physical and biological properties, as shown in Table 1 for details.
实施例10阿司匹林胃漂浮制剂Embodiment 10 aspirin gastric flotation preparation
制备2mg/ml的阿司匹林水溶液;取出20ml,将实施例5所得样品加入其中;待其将阿司匹林水溶液完全吸收后,室温下干燥2天;装入0号胶囊即得。Prepare a 2mg/ml aqueous aspirin solution; take out 20ml, add the sample obtained in Example 5 into it; wait for it to completely absorb the aspirin aqueous solution, dry it at room temperature for 2 days; pack it into a No. 0 capsule.
实施例11胰岛素口服给药系统Embodiment 11 Oral insulin delivery system
胰岛素首先用0.1N的HCl溶解,加水制得2mg/ml的溶液;取出15ml,将实施例5所得样品加入其中;待其将胰岛素溶液完全吸收后,室温下干燥2天;装入0号肠溶胶囊即得。Insulin was first dissolved with 0.1N HCl, and water was added to obtain a 2mg/ml solution; 15ml was taken out, and the sample obtained in Example 5 was added to it; after it completely absorbed the insulin solution, it was dried at room temperature for 2 days; Dissolve the capsules.
Claims (15)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03142231 CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03142231 CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1488331A true CN1488331A (en) | 2004-04-14 |
| CN1253147C CN1253147C (en) | 2006-04-26 |
Family
ID=34155669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03142231 Expired - Fee Related CN1253147C (en) | 2003-08-13 | 2003-08-13 | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1253147C (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101836970A (en) * | 2010-04-13 | 2010-09-22 | 南京大学 | Polyacrylic acid nano-gel microspheres, preparation method and application thereof |
| US8513353B2 (en) | 2009-03-19 | 2013-08-20 | Agency For Science, Technology And Research | Forming copolymer from bicontinuous microemulsion comprising monomers of different hydrophilicity |
| CN103773532A (en) * | 2014-01-27 | 2014-05-07 | 华南理工大学 | Method for purifying acid gas in natural gas |
| CN104288095A (en) * | 2014-01-15 | 2015-01-21 | 南京大学 | Floating gel for delivering pharmacological active substances in bladder and pharmaceutical preparation thereof |
| CN106470673A (en) * | 2014-02-25 | 2017-03-01 | 奥库利维公司 | Polymer Formulations for Nasolacrimal Stimulation |
| CN107591540A (en) * | 2017-08-27 | 2018-01-16 | 长沙小新新能源科技有限公司 | A kind of preparation method of biological fuel cell anode material |
| US10328262B2 (en) | 2010-11-16 | 2019-06-25 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| CN110124245A (en) * | 2019-06-04 | 2019-08-16 | 北京理工大学 | Foam Sodium Alginate Hydrogel Films and preparation method thereof, extinguishing device |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| US10537469B2 (en) | 2013-03-12 | 2020-01-21 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
| US10610095B2 (en) | 2016-12-02 | 2020-04-07 | Oculeve, Inc. | Apparatus and method for dry eye forecast and treatment recommendation |
| US10610695B2 (en) | 2014-10-22 | 2020-04-07 | Oculeve, Inc. | Implantable device for increasing tear production |
| US10722713B2 (en) | 2014-07-25 | 2020-07-28 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| US10722718B2 (en) | 2010-11-16 | 2020-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US10780273B2 (en) | 2014-10-22 | 2020-09-22 | Oculeve, Inc. | Stimulation devices and methods for treating dry eye |
| US10799695B2 (en) | 2013-04-19 | 2020-10-13 | Oculeve, Inc. | Nasal stimulation devices and methods |
| US10918864B2 (en) | 2016-05-02 | 2021-02-16 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
| CN112370418A (en) * | 2020-11-20 | 2021-02-19 | 湖北科技学院 | Radiation synthesis method of superporous hydrogel-based gastric retention agent |
| US10940310B2 (en) | 2016-02-19 | 2021-03-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| CN113613631A (en) * | 2019-10-11 | 2021-11-05 | 牛津医疗产品有限公司 | Plasticized superporous hydrogels |
| CN114853954A (en) * | 2022-07-06 | 2022-08-05 | 山东诺尔生物科技有限公司 | Preparation method of carbomer resin and carbomer resin |
-
2003
- 2003-08-13 CN CN 03142231 patent/CN1253147C/en not_active Expired - Fee Related
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8513353B2 (en) | 2009-03-19 | 2013-08-20 | Agency For Science, Technology And Research | Forming copolymer from bicontinuous microemulsion comprising monomers of different hydrophilicity |
| CN101836970A (en) * | 2010-04-13 | 2010-09-22 | 南京大学 | Polyacrylic acid nano-gel microspheres, preparation method and application thereof |
| US10835748B2 (en) | 2010-11-16 | 2020-11-17 | Oculeve, Inc. | Stimulation devices and methods |
| US10722718B2 (en) | 2010-11-16 | 2020-07-28 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US11771908B2 (en) | 2010-11-16 | 2023-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treatment of dry eye |
| US10328262B2 (en) | 2010-11-16 | 2019-06-25 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
| US10537469B2 (en) | 2013-03-12 | 2020-01-21 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
| US10799695B2 (en) | 2013-04-19 | 2020-10-13 | Oculeve, Inc. | Nasal stimulation devices and methods |
| US10967173B2 (en) | 2013-04-19 | 2021-04-06 | Oculeve, Inc. | Nasal stimulation devices and methods for treating dry eye |
| US10835738B2 (en) | 2013-04-19 | 2020-11-17 | Oculeve, Inc. | Nasal stimulation devices and methods |
| CN104288095A (en) * | 2014-01-15 | 2015-01-21 | 南京大学 | Floating gel for delivering pharmacological active substances in bladder and pharmaceutical preparation thereof |
| CN104288095B (en) * | 2014-01-15 | 2017-07-07 | 南京大学 | A kind of floating gel and its pharmaceutical preparation for delivering pharmacological active substance in bladder |
| CN103773532B (en) * | 2014-01-27 | 2015-12-09 | 华南理工大学 | The purifying treatment method of sour gas in a kind of Sweet natural gas |
| CN103773532A (en) * | 2014-01-27 | 2014-05-07 | 华南理工大学 | Method for purifying acid gas in natural gas |
| CN106470673B (en) * | 2014-02-25 | 2020-01-31 | 奥库利维公司 | Polymer formulations for nasolacrimal irritation |
| CN106470673A (en) * | 2014-02-25 | 2017-03-01 | 奥库利维公司 | Polymer Formulations for Nasolacrimal Stimulation |
| US10799696B2 (en) | 2014-02-25 | 2020-10-13 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
| US10722713B2 (en) | 2014-07-25 | 2020-07-28 | Oculeve, Inc. | Stimulation patterns for treating dry eye |
| US10610695B2 (en) | 2014-10-22 | 2020-04-07 | Oculeve, Inc. | Implantable device for increasing tear production |
| US10780273B2 (en) | 2014-10-22 | 2020-09-22 | Oculeve, Inc. | Stimulation devices and methods for treating dry eye |
| US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
| US10940310B2 (en) | 2016-02-19 | 2021-03-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
| US10918864B2 (en) | 2016-05-02 | 2021-02-16 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
| US10610095B2 (en) | 2016-12-02 | 2020-04-07 | Oculeve, Inc. | Apparatus and method for dry eye forecast and treatment recommendation |
| CN107591540A (en) * | 2017-08-27 | 2018-01-16 | 长沙小新新能源科技有限公司 | A kind of preparation method of biological fuel cell anode material |
| CN110124245A (en) * | 2019-06-04 | 2019-08-16 | 北京理工大学 | Foam Sodium Alginate Hydrogel Films and preparation method thereof, extinguishing device |
| CN113613631A (en) * | 2019-10-11 | 2021-11-05 | 牛津医疗产品有限公司 | Plasticized superporous hydrogels |
| CN113613631B (en) * | 2019-10-11 | 2025-06-20 | 牛津医疗产品有限公司 | Plasticized superporous hydrogels |
| CN112370418A (en) * | 2020-11-20 | 2021-02-19 | 湖北科技学院 | Radiation synthesis method of superporous hydrogel-based gastric retention agent |
| CN114853954A (en) * | 2022-07-06 | 2022-08-05 | 山东诺尔生物科技有限公司 | Preparation method of carbomer resin and carbomer resin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1253147C (en) | 2006-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1253147C (en) | Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof | |
| CN1302050C (en) | Interpenetrating network polymer type super porous aquogel, its prepn. method and application | |
| CN1259045A (en) | Method for oral delivery of proteins | |
| CN1209091C (en) | hard capsule | |
| US5750585A (en) | Super absorbent hydrogel foams | |
| CN1181816C (en) | Swelling and deswelling polymer blends | |
| JP5912126B2 (en) | Pharmaceutical dosage form | |
| CN1211076C (en) | Delivery devices and methods using preformed biodegradable polymer compositions | |
| US20190216729A1 (en) | Gastric Retention and Controlled Release Delivery System | |
| US8975309B2 (en) | Vinyl alcohol co-polymer cryogels, vinyl alcohol co-polymers, and methods and products thereof | |
| US20020122828A1 (en) | Hybrid porous materials for controlled release | |
| CN1466452A (en) | Composition for transdermal delivery of fentanyl | |
| CN100342912C (en) | Sustained release composition for oral administration of drugs | |
| CN108653196A (en) | A kind of liposome Composite Double response carries the preparation method of liquid medicine gel | |
| CN104105480A (en) | Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of drug-delivery composition | |
| US10653783B2 (en) | Sustained release of bioactive factors from zwitterionic hydrogels | |
| CN1241198A (en) | New Polymer Gel and Its Application | |
| CN1942207A (en) | Crosslinkable skin care adhesive | |
| Bajpai et al. | In vitro release dynamics of insulin from a loaded hydrophilic polymeric network | |
| CN1576341A (en) | Hydrophilc multi-component mixture Pressure-sensitive adhesive and application thereof | |
| CN1642575A (en) | Test system for evaluating the compatibility of biologically active substances with copolymers | |
| CN1048659A (en) | The preparation method of aqueogel and xerogel preparation | |
| US20080206339A1 (en) | Very-pure superporous hydrogels having outstanding swelling properties | |
| JPS58501034A (en) | Polymer diffusion matrix containing propranolol | |
| WO2024242163A1 (en) | Method for manufacturing microneedle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |